Paper1255804
Murine colon adenocarcinomas: methods for selective culture in vitro.
Tan MH and 2 others. J Natl Cancer Inst, 1976. Cited by 32 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Murine colon adenocarcinomas: methods for selective culture in vitro. Papers, record 1255804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1255804
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Cell Line | Major topic |
| Colonic Neoplasms | Major topic |
| Cell Separation | |
| Cells, Cultured | |
| Neoplasms, Experimental | |
| Trypsin |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,627,265 | Assessment of molecular modulation by multifrequency electromagnetic pulses to preferably eradicate tumorigenic cells. | Sci Rep | 2024 | https://conductscience.org/library/papers/39627265 | PubMed |
| 36,912,188 | Characterization of immune cell populations in syngeneic murine tumor models. | Cancer Med | 2023 | https://conductscience.org/library/papers/36912188 | PubMed |
| 31,200,747 | B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors. | J Immunother Cancer | 2019 | https://conductscience.org/library/papers/31200747 | PubMed |
| 26,238,780 | Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen. | Cancer Res | 2015 | https://conductscience.org/library/papers/26238780 | PubMed |
| 24,216,477 | Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation. | J Clin Invest | 2013 | https://conductscience.org/library/papers/24216477 | PubMed |
| 15,772,692 | Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction. | Gene Ther | 2005 | https://conductscience.org/library/papers/15772692 | PubMed |
| 12,739,068 | Interferon-alpha and interleukin-12 gene therapy of cancer: interferon-alpha induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing. | Cancer Immunol Immunother | 2003 | https://conductscience.org/library/papers/12739068 | PubMed |
| 11,854,515 | Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/11854515 | PubMed |
| 10,637,450 | Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models. | Gene Ther | 1999 | https://conductscience.org/library/papers/10637450 | PubMed |
| 7,182,348 | Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. | In Vitro | 1982 | https://conductscience.org/library/papers/7182348 | PubMed |
| 6,561,065 | Inhibition of liver metastases in murine colon adenocarcinoma by liposomes containing human C-reactive protein or crude lymphokine. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6561065 | PubMed |
| 3,611,191 | Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation. | J Cell Biol | 1987 | https://conductscience.org/library/papers/3611191 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1255804
GET https://conductscience.org/api/papers/v1/1255804/authors